(Q39272853)

10 September 2017

1 reference

title

Virus-host interplay in hepatitis B virus infection and epigenetic treatment strategies (English)

1 reference

10 September 2017

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28457020%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Kai O Hensel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28457020%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Julio C Rendon

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28457020%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Maria-Cristina Navas

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28457020%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Marianne G Rots

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28457020%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

language of work or name

English

0 references

publication date

29 April 2017

1 reference

10 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28457020%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

284

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28457020%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28457020%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

3550-3572

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28457020%20AND%20SRC:MED&resulttype=core&format=json

Transgenerational epigenetic inheritance: myths and mechanisms

8 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Synthetic CpG islands reveal DNA sequence determinants of chromatin structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

CpG islands and the regulation of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Reversing histone methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Every amino acid matters: essential contributions of histone variants to mammalian development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Histone modifications and a choice of variant: a language that helps the genome express itself

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Regulation of chromatin by histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Epigenetic programming and reprogramming during development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Mechanisms of HBV-induced hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Molecular genetics of HBV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Hepatitis B virus-induced oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Fidelity of hepatitis B virus polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Molecular evolution of hepatitis B virus over 25 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Overview of hepatitis B viral replication and genetic variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Structural organization of the hepatitis B virus minichromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Regulatory elements of hepatitis B virus transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Regulatory mechanisms of viral hepatitis B and C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Requirement of the cyclic adenosine monophosphate response element-binding protein for hepatitis B virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Cyclin D2 plays a regulatory role in HBV replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Sirtuin 1 regulates hepatitis B virus transcription and replication by targeting transcription factor AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Transcription of hepatitis B virus covalently closed circular DNA is regulated by CpG methylation during chronic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Comparative analysis of CpG islands among HBV genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Regulation of hepatitis B virus ENI enhancer activity by hepatocyte-enriched transcription factor HNF3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Hepatitis B virus enhancer binds and is activated by the Hepatocyte nuclear factor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Control of hepatitis B virus at the level of transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Purification and properties of rat liver nuclear proteins that interact with the hepatitis B virus enhancer 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Differential regulation of hepatitis B virus gene expression by the Sp1 transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Core promoter: a critical region where the hepatitis B virus makes decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Characterization of the hepatitis B virus large surface antigen promoter Sp1 binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Characterization of the minimal elements of the hepatitis B virus large surface antigen promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Two control elements in the hepatitis B virus S-promoter are important for full promoter activity mediated by CCAAT-binding factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

The TATA-less promoter of hepatitis B virus S gene contains a TBP binding site and an active initiator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Enhancer I predominance in hepatitis B virus gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Characterization of a Specific Region in the Hepatitis B Virus Enhancer I for the Efficient Expression of X Gene in the Hepatic Cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Hepatitis B virus X gene expression is activated by X protein but repressed by p53 tumor suppressor gene product in the transient expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Stimulation of hepatitis B virus genome replication by HBx is linked to both nuclear and cytoplasmic HBx expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Replication of the hepatitis B virus requires a calcium-dependent HBx-induced G1 phase arrest of hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Dynamics of HBV cccDNA expression and transcription in different cell growth phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

The hepatitis B virus X protein modulates hepatocyte proliferation pathways to stimulate viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Hepatitis B virus X protein stimulates gene expression selectively from extrachromosomal DNA templates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

NIRF, a Novel Ubiquitin Ligase, Inhibits Hepatitis B Virus Replication Through Effect on HBV Core Protein and H3 Histones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Control of cccDNA function in hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Comprehensive DNA methylation analysis of hepatitis B virus genome in infected liver tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

DNA methylation of hepatitis B virus (HBV) genome associated with the development of hepatocellular carcinoma and occult HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Establishment and mitotic stability of an extra-chromosomal mammalian replicon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Molecular mechanisms underlying HBsAg negativity in occult HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Restitution of gene expression and histone acetylation signatures altered by hepatitis B virus through antiviral microRNA-like molecules in nontransformed murine hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Hepatitis virus infection affects DNA methylation in mice with humanized livers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Proteomic profiling identifies aberrant epigenetic modifications induced by hepatitis B virus X protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Epigenetic mechanisms in hepatocellular carcinoma: How environmental factors influence the epigenome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

DNA methylation in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

p16 Hypermethylation in the early stage of hepatitis B virus-associated hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Epigenetic treatment of solid tumours: a review of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Effects of SAHA on proliferation and apoptosis of hepatocellular carcinoma cells and hepatitis B virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

The hepatitis B virus ribonuclease H as a drug target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Zinc fingers, TAL effectors, or Cas9-based DNA binding proteins: what's best for targeting desired genome loci?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Zinc-finger nucleases: a panoramic view

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Design, construction and in vitro testing of zinc finger nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Zinc finger nuclease technology: advances and obstacles in modelling and treating genetic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

An efficient antiviral strategy for targeting hepatitis B virus genome using transcription activator-like effector nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

CRISPR-Cas immunity in prokaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Targeted gene knockout by direct delivery of zinc-finger nuclease proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Expression of CRISPR/Cas single guide RNAs using small tRNA promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

An improved zinc-finger nuclease architecture for highly specific genome editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Hepatitis B virus can be inhibited by DNA methyltransferase 3a via specific zinc-finger-induced methylation of the X promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Creation of a six-fingered artificial transcription factor that represses the hepatitis B virus HBx gene integrated into a human hepatocellular carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Epigenetic Editing: targeted rewriting of epigenetic marks to modulate expression of selected target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Synthetic epigenetics-towards intelligent control of epigenetic states and cell identity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Engineering of the epigenome: synthetic biology to define functional causality and develop innovative therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Gene-specific targeting of H3K9 methylation is sufficient for initiating repression in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Towards sustained silencing of HER2/neu in cancer by epigenetic editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Targeted methylation and gene silencing of VEGF-A in human cells by using a designed Dnmt3a-Dnmt3L single-chain fusion protein with increased DNA methylation activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Epigenetic reprogramming of cancer cells via targeted DNA methylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Functional validation of putative tumor suppressor gene C13ORF18 in cervical cancer by Artificial Transcription Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Re-expression of Selected Epigenetically Silenced Candidate Tumor Suppressor Genes in Cervical Cancer by TET2-directed Demethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Strategies for precision modulation of gene expression by epigenome editing: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Methylation regulates hepatitis B viral protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

An NF1 motif plays a central role in hepatitis B virus enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Characterization of the hepatitis B virus X- and nucleocapsid gene transcriptional regulatory elements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Insulin activates the hepatitis B virus X gene through the activating protein-1 binding site in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Repression of hepatitis B viral gene expression by transcription factor nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

The ubiquitous transcription factor Oct-1 and the liver-specific factor HNF-1 are both required to activate transcription of a hepatitis B virus promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Nuclear respiratory factor 1 plays an essential role in transcriptional initiation from the hepatitis B virus x gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

HNF3 binds and activates the second enhancer, ENII, of hepatitis B virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Characterization of the hepatitis B virus major surface antigen promoter hepatocyte nuclear factor 3 binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Critical roles of nuclear receptor response elements in replication of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Transcription and replication of a natural hepatitis B virus nucleocapsid promoter variant is regulated in vivo by peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Limited effects of bile acids and small heterodimer partner on hepatitis B virus biosynthesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Differential inhibition of nuclear hormone receptor-dependent hepatitis B virus replication by the small heterodimer partner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Collective repression of the hepatitis B virus enhancer II by human TR4 and TR2 orphan receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Suppression of hepatitis B virus core promoter by the nuclear orphan receptor TR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Enhancement of hepatitis-B surface-antigen expression by 5-azacytidine in a hepatitis-B-virus-transfected cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Demethylation by 5-azacytidine results in the expression of hepatitis B virus surface antigen in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Decreased PADI4 mRNA association with global hypomethylation in hepatocellular carcinoma during HBV exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

SIRT1 sensitizes hepatocellular carcinoma cells expressing hepatitis B virus X protein to oxidative stress-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Resveratrol- induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

The antimetastatic effects of resveratrol on hepatocellular carcinoma through the downregulation of a metastasis-associated protease by SP-1 modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Abrogation of G2/M arrest sensitizes curcumin-resistant hepatoma cells to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Curcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

AAV-mediated delivery of zinc finger nucleases targeting hepatitis B virus inhibits active replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Targeting Hepatitis B Virus With CRISPR/Cas9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Dual gRNAs guided CRISPR/Cas9 system inhibits hepatitis B virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

Targeting hepatitis B virus cccDNA using CRISPR/Cas9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

CRISPR/Cas9 produces anti-hepatitis B virus effect in hepatoma cells and transgenic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14094

21 January 2018

Identifiers

DOI

10.1111/FEBS.14094

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28457020%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28457020%20AND%20SRC:MED&resulttype=core&format=json